Evidence map›Paper›PMID 7545031›Full record

ArticleMolecular biology of the cell1995

Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.

M Kato, S Saunders, H Nguyen, M Bernfield

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 216 citations in OpenAlex.

  1. Targeting syndecan-1: new opportunities in cancer therapy.American journal of physiology. Cell physiology · 2022
    Review
  2. Article
  3. Coreceptor functions of cell surface heparan sulfate proteoglycans.American journal of physiology. Cell physiology · 2022
    Review
  4. Studying Viscoelastic Changes of Skin Cells Using QCM-D Measurements.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. Article
  6. Syndecan-1 (CD138), Carcinomas and EMT.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Role of the Extracellular Matrix in Cancer Stemness.Frontiers in cell and developmental biology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M KatoJoint Program in Neonatology, Harvard Medical School, Boston, Massachusetts 02115, USA.
S Saunders
H Nguyen
M Bernfield
Harvard University · US

Funding

PROTEOGLYCANS AND BASAL LAMINA STRUCTURE/FUNCTIONR01CA028735 · NCI · STANFORD UNIVERSITY · PI SILVERMAN, GARY ARTHUR · 1985 to 2002
$1.3M
SCOR-LUNG BIOLOGY AND DISEASES IN INFANTS AND CHILDRENP50HL046491 · NHLBI · CHILDREN'S HOSPITAL BOSTON · 1992 to 1996
–
NCI NIH HHS CA-28735NHLBI NIH HHS HL-46491NICHD NIH HHS HD-0673
6 · The paper itself

Abstract

Simple epithelial cells are polygonal in shape, polarized in an apical-basal orientation, and organized into closely adherent sheets, characteristics that result from a variety of cellular specializations and adhesive proteins. These characteristics are lost when the epithelia transform during embryogenesis into mesenchymal cells or after neoplasia into invasive carcinoma cells. Of the syndecan family of transmembrane heparan sulfate proteoglycans, simple epithelia produce predominantly syndecan-1, which is found at basolateral surfaces and within adhesive junctions. To elucidate the function of this syndecan-1, normal murine mammary gland epithelia were made deficient in syndecan-1 by transfection with an expression vector containing the syndecan-1 cDNA in the antisense configuration. Several independently derived clones of stable transfectants contained the antisense cDNA in their genome and expressed the antisense transcript. These grew either as epithelial islands of closely adherent polygonal cells, identical to both the parental cells and the vector-only control transfectants, or as individual elongated fusiform cells that invaded and migrated within collagen gels, like mesenchymal cells, but were anchorage-independent for growth. The clones that retained epithelial characteristics were moderately deficient in cell surface syndecan-1 (greater than 48% of control levels) but did not differ from control cells in expression of beta 1-integrins and E-cadherin, or in F-actin organization. However, the clones of fusiform cells were severely deficient in cell surface syndecan-1 (less than 12% of control levels) and showed rearranged beta 1-integrins, markedly reduced E-cadherin expression, and disorganized F-actin filaments, but retained mammary epithelial markers. Therefore, depleting epithelia of cell surface syndecan-1 alters cell morphology and organization, the arrangement and expression of adhesion molecules, and anchorage-dependent growth controls. Thus, cell surface syndecan-1 is required to maintain the normal phenotype of simple epithelia.

Indexed as

Epithelial CellsActinsAnimalsCadherinsCell AdhesionCell LineGenetic VectorsIntegrin beta1IntegrinsMammary Glands, AnimalMembrane GlycoproteinsMesodermMiceMorphogenesisPhenotypeProteoglycansActinsCadherinsIntegrin beta1IntegrinsMembrane GlycoproteinsProteoglycansRNA, AntisenseSdc1 protein, mouseSyndecan-1Syndecans

Identifiers

PMID7545031
PMCPMC301215
OpenAlexW2020645947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.